Absci Corporation (ABSI) vs Novavax, Inc. (NVAX)
Absci Corporation and Novavax, Inc. are both Biotechnology companies. Absci Corporation and Novavax, Inc. are of similar size ($1.8B and $1.8B). Novavax, Inc. grew revenue faster over the last twelve months: −61.6% against −62.3%. Novavax, Inc. has the higher net margin (−59.9% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 17 metrics below, Novavax, Inc. leads on 14 and Absci Corporation on 3.
Valuation
Profitability
| Metric | ABSI | NVAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 78.60% | 65.16% |
| Operating margin | (8,084.50%) | (56.58%) | 0.00% |
| Net margin | (7,756.37%) | (59.87%) | 0.00% |
| Free cash flow margin | (6,969.83%) | (10.20%) | 0.00% |
| Return on equity | (57.72%) | 323.66% | (57.72%) |
| Return on assets | (50.57%) | (21.62%) | (49.22%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack